Reverse Myocardial Remodeling Following Valve Replacement

After aortic valve replacement, focal fibrosis does not resolve, but diffuse fibrosis and cell hypertrophy regress. As expected, this regression comes with structural and functional improvement that suggest it is a dynamic process. Fibrosis can be measured and quantified with cardiovascular MR, which makes it a potential therapeutic objective.

Remodelado miocárdico reverso luego del reemplazo valvularLeft ventricular hypertrophy is a key process of many cardiomyopathies and results from cell hypertrophy and the expansion of extracellular matrix (interstitial fibrosis). This study looked at whether myocardial hypertrophy and interstitial fibrosis in the context of severe aortic stenosis are a dynamic process that can be reversed.

The study included 181 symptomatic patients with severe aortic stenosis (valve indexed area 0.4 ± 0.1 cm2/m2) scheduled for valve replacement. Patients were assessed with ECG and cardiovascular MR prior procedure (assessing volume, function, local and diffuse fibrosis), with bio markers (Pro BNP and ultrasensitive T troponin) and 6-minute walk test.


Read also: What’s New in the European Guidelines on Peripheral Arterial Disease.


MR was used to measure extracellular volume fraction, deriving matrix mass volume and cell volume. Biopsy ruled out other subjacent heart conditions and all measurements were repeated one year after valve replacement.

116 patients that did not require pacemaker, showed, at one year, a significant improvement of mean gradient (48±16 mm Hg to 12±6 mm Hg; p<0.001) and ventricular mass decreased a significant 19%. Focal fibrosis in MR with gadolinium saw no change but extracellular volume fraction increased thanks to a 16% reduction of matrix volume and a proportionally higher reduction of cell volume.


Read also: ACC 2018 | DEFINE-FLAIR Sub-Analysis: iFR More Comfortable, Faster, and Much Cheaper.


All these changes were followed by improved diastolic function, reduced Pro BNP levels, improved 6-minute walk test and functional class.

Conclusion

Diffuse fibrosis and cell hypertrophy regress after valve replacement, which brings on structural and functional improvement.

Original title: Reverse Myocardial Remodeling Following Valve Replacement in Patients with Aortic Stenosis.

Reference: Thomas A. Treibel et al. J Am Coll Cardiol 2018;71:860–71.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry

Courtesy of Dr. Juan Manuel Pérez. Mitral transcatheter edge-to-edge repair (M-TEER) is an effective option for patients with severe mitral regurgitation who are at high...

Left Bundle Branch Block after TAVR: What Is Its Impact?

Courtesy of Dr. Juan Manuel Pérez. Left bundle branch block (LBBB) is a common complication following transcatheter aortic valve replacement (TAVR), which can be either...

Multicenter Experience with 3D Intracardiac Echocardiography for Guiding Interventional Cardiac Procedures

Courtesy of Dr. Juan Manuel Pérez. Imaging techniques play a fundamental role in interventional cardiac procedures. Intracardiac echocardiography (ICE) appears as an alternative to transesophageal...

Pathology of Self-Expanding Transcatheter Aortic Bioprostheses and Hypoattenuated Leaflet Thickening

Courtesy of Dr. Juan Manuel Pérez. Despite the available long term followup data on of transcatheter aortic valve replacement (TAVR), bioprosthesis durability continues under debate....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...